INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

BIIBBIOGEN INC.

CIK 0000875045

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells5 / 3
Max Insider Score35
Connections8with evidence

BIIB · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
Maria Elvira SalazarRSelf
BIIBBIOGEN INC.
Partial sale
SELL$1,001 – $15KSep 24, 2026Oct 7, 2026
traded Sep 24, 2026
+13dHOUSE PTR

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Connected organizationevidence
    BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'FEC Form 1 connected organization: BIOGEN INC (curated map) · Nov 4, 2026
  • ← Disclosed trade inevidence
    Maria Elvira SalazarSale disclosed 2026-10-07 · Oct 7, 2026
  • ← Disclosed trade inevidence
    Kevin HernSale disclosed 2026-09-01 · Sep 1, 2026
20
Kevin HernRSelf
BIIBBIOGEN INC.
Sale
SELL
$1,001 – $15K
Aug 18, 2026
Sep 1, 2026
traded Aug 18, 2026
+14d
HOUSE PTR

Evidence

35
Maria Elvira SalazarRSelf
BIIBBIOGEN INC.
Sale
SELL$15K – $50KJun 2, 2026Jul 7, 2026
traded Jun 2, 2026
+35dHOUSE PTR

Evidence

20
Gilbert Ray Cisneros, Jr.DSelf
BIIBBIOGEN INC.
Purchase
BUY$1,001 – $15KJun 5, 2026Jul 2, 2026
traded Jun 5, 2026
+27dHOUSE PTR

Evidence

20
Maria Elvira SalazarRSelf
BIIBBIOGEN INC.
Purchase
BUY$1,001 – $15KMay 12, 2026Jun 8, 2026
traded May 12, 2026
+27dHOUSE PTR

Evidence

34
Maria Elvira SalazarRSelf
BIIBBIOGEN INC.
Purchase
BUY$50K – $100KMay 11, 2026Jun 8, 2026
traded May 11, 2026
+28dHOUSE PTR

Evidence

24
Maria Elvira SalazarRSelf
BIIBBIOGEN INC.
Purchase
BUY$1,001 – $15KMay 11, 2026Jun 8, 2026
traded May 11, 2026
+28dHOUSE PTR

Evidence

24
Gilbert Ray Cisneros, Jr.DSelf
BIIBBIOGEN INC.
Purchase
BUY$1,001 – $15KJan 30, 2026Feb 13, 2026
traded Jan 30, 2026
+14dHOUSE PTR

Evidence

  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    FEDERAL STREET STRATEGIES, LLCLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    DLA PIPER LLP (US)LDA Q1 2026 first quarter · Taxation, Trade, Health issues, MED, Pharmacy, Copyright/patent · Aug 26, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-07-02 · Jul 2, 2026

    • Lobbying

    $2.52M reported · de-duplicated
    2026 Q2 $1.06M in-house2026 Q1 $1.46M in-house
    • FEDERAL STREET STRATEGIES, LLC$50K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • In-house report$1.46M2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues, Pharmacy, Taxation, Trade
    • DLA PIPER LLP (US)$60K2026 Q2 · posted Aug 26, 2026 · Pharmacy, Copyright/patent, Health issues, MED, Taxation, Trade
    • TODD STRATEGY GROUP$50K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • In-house report$1.06M2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Pharmacy, Taxation, Trade
    • TODD STRATEGY GROUP$50K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • DLA PIPER LLP (US)$60K2026 Q1 · posted Aug 26, 2026 · Taxation, Trade, Health issues, MED, Pharmacy, Copyright/patent
    • FEDERAL STREET STRATEGIES, LLC$50K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members
    • Lori TrahanD$5,000BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
    • Kevin HernR$5,000BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
    • Richard HudsonR$4,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
    • Brett GuthrieR$4,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
    • H. Morgan GriffithR$3,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
  • John JoyceR$3,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
  • Gregory F. MurphyR$3,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
  • Donald G. DavisD$3,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
  • Gus M. BilirakisR$3,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
  • Valerie P. FousheeD$3,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
  • Nicholas A. LangworthyR$3,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'
  • Kevin MullinD$3,500BIOGEN INC. POLITICAL ACTION COMMITTEE A.K.A 'BIOGEN PAC'